Chronic citalopram treatment ameliorates depressive behavior associated with light at night.
نویسندگان
چکیده
Chronic exposure to light at night (LAN) is a circadian disruptor and may be linked to various health risks, including mood disorders. We recently demonstrated that chronic exposure to dim (5 lux) LAN provokes depressive-like behaviors and reduced hippocampal CA1 dendritic spine density in female hamsters. Whether this model is responsive to selective serotonin reuptake inhibitors remains unspecified. In this study, we exposed hamsters to 5 lux LAN and treated with citalopram to determine effects on depressive-like behavior and CA1 dendritic spine density. Female hamsters were ovariectomized at adulthood and housed in either a standard light-dark cycle (LD) or dim LAN (dLAN). After 4 weeks exposure, treatment with either citalopram or vehicle was administered for 2 weeks while hamsters remained in experimental lighting conditions. Depressive-like behavior was assayed using the forced swim test and brains were processed for Golgi-Cox staining and analyzed for dendritic spine density. Treatment with citalopram rescued behavior in the forced swim test in hamsters housed in dLAN, but had no effect on hamsters housed in LD. Dendritic spine density in CA1 was moderately improved by citalopram treatment, but not fully restored. These results validate our LAN paradigm as a depression model by showing citalopram selectively improves depressive-like behavior in dLAN conditions, but not in LD conditions. These data also suggest standard SSRI therapy may be effective for individuals experiencing depression related to circadian disruption and LAN exposure, such as shift workers.
منابع مشابه
Citalopram Ameliorates Impairments in Spatial Memory and Synaptic Plasticity in Female 3xTgAD Mice
Alzheimer's disease (AD) is the primary cause of dementia. There is no effective treatment. Amyloid-β peptide (Aβ) plays an important role in the pathogenesis and thus strategies suppressing Aβ production and accumulation seem promising. Citalopram is an antidepressant drug and can decrease Aβ production and amyloid plaques in transgenic mice of AD and humans. Whether citalopram can ameliorate ...
متن کاملMorning light treatment hastens the antidepressant effect of citalopram: a placebo-controlled trial.
BACKGROUND Selective serotonin reuptake inhibitors are effective in approximately 70% of patients with a major depressive episode, but therapeutic changes usually require 2 weeks of administration to become clinically relevant. Adjunct light therapy has been proposed to hasten the effects of drug treatment. The purpose of the present study was to evaluate the effect of morning light therapy or ...
متن کاملDepression, Anxiety, and Quality of Life in Breast Cancer Patients with Depression Receiving Citalopram and Supportive Group Psychotherapy: A Six-month Longitudinal Study
Background and purpose: Depression is a common psychiatric disorder in patients with breast cancer. This study was performed to follow-up breast cancer patients with depression receiving citalopram and group psychotherapy for six months. Materials and methods: This clinical trial was conducted in 40 breast cancer patients with depressive disorder. Among the patients, 20 received citalopram (20...
متن کاملTowards limiting QT interval prolongation and arrhythmia risk in citalopram use.
Citalopram is a serotonin-selective reuptake inhibitor (SSRI) widely used in the treatment of major depression and sometimes also anxiety-associated conditions, obsessive compulsive disorder and behavior disturbances associated with dementia [1, 2]. Citalopram is relatively well tolerated and has been considered to have comparatively low potential for drug–drug interactions and anti-adrenergic ...
متن کاملThe relationship between the acute cerebral metabolic response to citalopram and chronic citalopram treatment outcome.
OBJECTIVES Given the challenges in the clinical management of geriatric depression, research over the past decade has focused on developing early neurobiological markers of antidepressant treatment response. This study tested the hypothesis that lower baseline glucose metabolism and greater acute cerebral metabolic responses to a single, intravenous (IV) dose of the selective serotonin reuptake...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Behavioral neuroscience
دوره 126 5 شماره
صفحات -
تاریخ انتشار 2012